Early research (Phase 1)Study completedNCT02949999What this trial is testingVoclosporin in Healthy Japanese VolunteersWho this might be right forVolunteers Aurinia Pharmaceuticals Inc. 40
Early research (Phase 1)Study completedNCT06139302What this trial is testingTest How Different Doses of Nerandomilast (BI 1015550) Are Taken up in the Body of Healthy Japanese MenWho this might be right forHealthy Boehringer Ingelheim 12
Early research (Phase 1)Ended earlyNCT05794672What this trial is testingInvestigate the Safety, Tolerability and Pharmacokinetics of Elarekibep in Healthy Japanese SubjectsWho this might be right forHealthy Subjects (Indication: Asthma) AstraZeneca 30
Early research (Phase 1)Study completedNCT00772759What this trial is testingAssess Safety, Tolerability and PK of AZD3199 in JapaneseWho this might be right forHealthy AstraZeneca 27
Large-scale testing (Phase 3)Study completedNCT01900444What this trial is testingStudy of a Booster Dose of IMOJEV® One Year After Primary Immunization in Healthy Children in South KoreaWho this might be right forJapanese Encephalitis Sanofi Pasteur, a Sanofi Company 119
Early research (Phase 1)Study completedNCT02185534What this trial is testingClopidogrel Bioequivalence Study in Healthy SubjectsWho this might be right forBioequivalence, AUC, Cmax, Pharmacokinetics AstraZeneca 144
Early research (Phase 1)Study completedNCT02141711What this trial is testingTAK-438 - Safety, Blood Levels & Effects of Repeated DosesWho this might be right forErosive Esophagitis(EE)Gastroesophageal Reflux Disease (GERD) Takeda 48
Early research (Phase 1)Study completedNCT04384081What this trial is testingTest How Different Doses of BI 456906 Are Tolerated in Japanese Men With a Body Mass Index (BMI) Between 23 and 40 kg/m2Who this might be right forHealthy Boehringer Ingelheim 37
Early research (Phase 1)Study completedNCT03096795What this trial is testingSafety and Tolerability of MEDI3506 in Healthy Participants, in Participants With COPD and Healthy Japanese ParticipantsWho this might be right forPart I (SAD) - Healthy ParticipantsPart II (MAD) - Chronic Obstructive Pulmonary DiseasePart III (J-SD) - Healthy Japanese Participants MedImmune LLC 88
Early research (Phase 1)WithdrawnNCT03747926What this trial is testingThis Study is Done in Healthy Japanese Volunteers. It Looks at How Different Doses of BI 705564 Are Taken up in the Body and How Well They Are ToleratedWho this might be right forHealthy Boehringer Ingelheim
Early research (Phase 1)Study completedNCT03436849What this trial is testingAssess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ESN364 in Healthy Japanese Male and Pre- and Post-menopausal Female SubjectsWho this might be right forHealthy Subjects Astellas Pharma Inc 44
Early research (Phase 1)Study completedNCT04269538What this trial is testingEvaluation of Safety, Tolerability and Pharmacokinetics of Single Dose of PF-06480605 in Japanese Healthy ParticipantsWho this might be right forHealthy Telavant, Inc. 16
Early research (Phase 1)Study completedNCT04940364What this trial is testingExamine the Safety, Tolerability and Biological Effects of Single Doses of Subcutaneously and Intravenously Administered Pozelimab as Monotherapy and in Combination With Single Doses of Subcutaneously Administered Cemdisiran in Adult Japanese Healthy VolunteersWho this might be right forHealthy Regeneron Pharmaceuticals 30
Early research (Phase 1)Study completedNCT04878406What this trial is testingA Research Study of How the Medicine NNC0480-0389 Taken With Semaglutide Works in the Body of Healthy Japanese MenWho this might be right forHealthy Volunteers Type 2 Diabetes Novo Nordisk A/S 24
Early research (Phase 1)Study completedNCT02537405What this trial is testingBioequivalence Study of Rivaroxaban in Japanese Healthy Adult Male SubjectsWho this might be right forEmbolism, Atrial Fibrillation and Venous Thrombosis Bayer 40
Early research (Phase 1)Study completedNCT02225288What this trial is testingE2022 Tape Formulation (Overlay-integrated E2022 18 mg Tape Formulation) for Different Application Sites and Intervals in Japanese Healthy Elderly MalesWho this might be right forHealthy Subjects Eisai Co., Ltd. 48
Early research (Phase 1)Study completedNCT05955183What this trial is testingStudy to Assess the Safety, Tolerability and Pharmacokinetics of AZD5055 in Japanese and Chinese Healthy Volunteers..Who this might be right forHealthy Participants AstraZeneca 38
Early research (Phase 1)Study completedNCT06093542What this trial is testingInvestigate the Safety, Tolerability, and Pharmacokinetics of AZD7503 in Japanese Healthy Participants.Who this might be right forHeathy Participants AstraZeneca 12
Early research (Phase 1)Study completedNCT01815827What this trial is testingSingle Dose Inclacumab in Japanese Healthy Volunteers Compared to Caucasian Healthy VolunteersWho this might be right forHealthy Volunteer Hoffmann-La Roche 62
Early research (Phase 1)Study completedNCT01622283What this trial is testingPharmacokinetic Study of Levocetirizine Oral SolutionWho this might be right forRhinitis, Allergic, Perennial and Seasonal GlaxoSmithKline 20